Promising Medical Stocks To Keep An Eye On - November 15th

Key Points

• MarketBeat’s medical-stock watchlist names Stryker, Danaher, Humana, Gilead Sciences, McKesson, Medtronic and HCA Healthcare, selected for their high recent dollar trading volume.
• Friday trading was mixed: McKesson rose $26.26, while Humana, Danaher, Gilead Sciences and Medtronic also gained; Stryker and HCA Healthcare declined.
• Several stocks were near their 12-month highs, including McKesson at $1,103.31 versus a $1,121.50 high and Humana at $450.38 versus $456.50.

Stryker, Danaher, Humana, Gilead Sciences, McKesson, Medtronic, and HCA Healthcare are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies that develop, manufacture, or provide healthcare-related products and services, such as pharmaceuticals, medical devices, biotechnology, and healthcare services. Investors may group them as a sector, though their performance can be affected by factors like clinical-trial results, regulation, and healthcare demand. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Stryker (SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

SYK traded down $3.34 during trading on Friday, hitting $309.05. The company's stock had a trading volume of 3,251,740 shares, compared to its average volume of 3,235,306. The firm has a market capitalization of $117.65 billion, a price-to-earnings ratio of 32.91, a P/E/G ratio of 2.14 and a beta of 0.78. Stryker has a twelve month low of $267.00 and a twelve month high of $389.33. The business's fifty day simple moving average is $292.30 and its 200 day simple moving average is $322.60. The company has a current ratio of 2.18, a quick ratio of 1.30 and a debt-to-equity ratio of 0.60.

Read Our Latest Research Report on SYK

Danaher (DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Shares of NYSE:DHR traded up $1.00 during midday trading on Friday, reaching $233.16. 3,359,470 shares of the company's stock traded hands, compared to its average volume of 4,152,061. Danaher has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a market cap of $164.04 billion, a P/E ratio of 38.16, a PEG ratio of 2.92 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The company has a fifty day simple moving average of $222.56 and a two-hundred day simple moving average of $201.52.

Read Our Latest Research Report on DHR

Humana (HUM)

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Humana stock traded up $6.70 during trading on Friday, reaching $450.38. The company had a trading volume of 1,499,042 shares, compared to its average volume of 1,566,553. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.74 and a current ratio of 1.65. The firm has a market capitalization of $54.09 billion, a PE ratio of 43.81, a price-to-earnings-growth ratio of 2.11 and a beta of 0.65. Humana has a 1-year low of $163.11 and a 1-year high of $456.50. The firm's 50-day simple moving average is $408.53 and its 200 day simple moving average is $316.91.

Read Our Latest Research Report on HUM

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

Gilead Sciences stock traded up $0.13 during midday trading on Friday, reaching $168.08. The company had a trading volume of 3,637,311 shares, compared to its average volume of 6,772,945. Gilead Sciences has a 12-month low of $116.88 and a 12-month high of $176.58. The firm's fifty day simple moving average is $155.10 and its 200-day simple moving average is $141.80. The company has a debt-to-equity ratio of 1.84, a current ratio of 1.38 and a quick ratio of 1.22. The company has a market capitalization of $208.48 billion, a P/E ratio of -53.19 and a beta of 0.35.

Read Our Latest Research Report on GILD

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

MCK stock traded up $26.26 during midday trading on Friday, reaching $1,103.31. The stock had a trading volume of 527,403 shares, compared to its average volume of 716,694. McKesson has a 52-week low of $723.68 and a 52-week high of $1,121.50. The company's fifty day simple moving average is $955.45 and its 200 day simple moving average is $874.53. The company has a market cap of $127.39 billion, a price-to-earnings ratio of 28.37, a price-to-earnings-growth ratio of 1.82 and a beta of 0.27.

Read Our Latest Research Report on MCK

Medtronic (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Shares of NYSE MDT traded up $1.85 during mid-day trading on Friday, reaching $102.84. The company's stock had a trading volume of 5,257,133 shares, compared to its average volume of 10,182,103. The stock has a 50-day moving average of $93.72 and a two-hundred day moving average of $88.47. The stock has a market capitalization of $131.54 billion, a P/E ratio of 25.33, a P/E/G ratio of 2.36 and a beta of 0.56. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.54 and a current ratio of 2.07. Medtronic has a 1-year low of $73.31 and a 1-year high of $106.33.

Read Our Latest Research Report on MDT

HCA Healthcare (HCA)

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

HCA traded down $1.84 on Friday, reaching $498.82. 971,100 shares of the company's stock were exchanged, compared to its average volume of 1,447,928. The stock has a market cap of $104.20 billion, a PE ratio of 16.53, a P/E/G ratio of 1.67 and a beta of 1.11. HCA Healthcare has a twelve month low of $353.99 and a twelve month high of $556.52. The stock's fifty day moving average price is $452.79 and its 200-day moving average price is $445.91.

Read Our Latest Research Report on HCA

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.